↓ Skip to main content

Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer

Overview of attention for article published in Journal of Translational Medicine, June 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
49 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer
Published in
Journal of Translational Medicine, June 2014
DOI 10.1186/1479-5876-12-175
Pubmed ID
Authors

Yoshitaro Shindo, Shoichi Hazama, Yoshinari Maeda, Hiroto Matsui, Michihisa Iida, Nobuaki Suzuki, Kiyoshi Yoshimura, Tomio Ueno, Shigefumi Yoshino, Kohei Sakai, Yutaka Suehiro, Takahiro Yamasaki, Yuji Hinoda, Masaaki Oka

Abstract

We previously reported the clinical efficacy of adoptive immunotherapy (AIT) with dendritic cells (DCs) pulsed with mucin 1 (MUC1) peptide and cytotoxic T lymphocytes (CTLs). We also reported that gemcitabine (GEM) enhances anti-tumor immunity by suppressing regulatory T cells. Therefore, in the present study, we performed combination therapy with AIT and GEM for patients with unresectable or recurrent pancreatic cancer.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 34 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 18%
Student > Ph. D. Student 5 15%
Student > Bachelor 4 12%
Other 4 12%
Student > Doctoral Student 1 3%
Other 4 12%
Unknown 10 29%
Readers by discipline Count As %
Medicine and Dentistry 7 21%
Agricultural and Biological Sciences 5 15%
Immunology and Microbiology 3 9%
Biochemistry, Genetics and Molecular Biology 2 6%
Chemistry 2 6%
Other 4 12%
Unknown 11 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 June 2014.
All research outputs
#14,782,026
of 22,757,541 outputs
Outputs from Journal of Translational Medicine
#1,972
of 3,978 outputs
Outputs of similar age
#127,484
of 228,247 outputs
Outputs of similar age from Journal of Translational Medicine
#29
of 68 outputs
Altmetric has tracked 22,757,541 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,978 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,247 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.